Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 474261 - 474280 out of 483426 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01DC04) ixabepilone | IXEMPRA KIT 15MG INJ OUTER CARTON | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | R-PharmUSLLC |
| USA | (L01DC04) ixabepilone | IXEMPRA KIT 15MG INJ OUTER CARTON | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | R-PharmUSLLC |
| USA | (L01DC04) ixabepilone | IXEMPRA KIT 45MG INJ OUTER CARTON | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | R-PharmUSLLC |
| USA | (L01DC04) ixabepilone | IXEMPRA KIT 45MG INJ OUTER CARTON | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | R-PharmUSLLC |
| USA | (L01EA01) imatinib (adm: O) | GLEEVEC 100MG TAB | 90 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
| USA | (L01EA01) imatinib (adm: O) | GLEEVEC 100MG TAB | 90 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
| USA | (L01EA01) imatinib (adm: O) | GLEEVEC 400MG | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
| USA | (L01EA01) imatinib (adm: O) | GLEEVEC 400MG | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
| USA | (L01EA01) imatinib (adm: O) | GLEEVEC 400MG | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
| USA | (L01EA01) imatinib (adm: O) | GLEEVEC 400MG | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
| USA | (L01EA02) dasatinib (adm: O) | SPRYCEL 100MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Bristol-MyersSquibbCompany |
| USA | (L01EA02) dasatinib (adm: O) | SPRYCEL 100MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Bristol-MyersSquibbCompany |
| USA | (L01EA02) dasatinib (adm: O) | SPRYCEL 140MG TABLETS | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Bristol-MyersSquibbCompany |
| USA | (L01EA02) dasatinib (adm: O) | SPRYCEL 140MG TABLETS | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Bristol-MyersSquibbCompany |
| USA | (L01EA02) dasatinib (adm: O) | SPRYCEL 20MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Bristol-MyersSquibbCompany |
| USA | (L01EA02) dasatinib (adm: O) | SPRYCEL 20MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Bristol-MyersSquibbCompany |
| USA | (L01EA02) dasatinib (adm: O) | SPRYCEL 50MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Bristol-MyersSquibbCompany |
| USA | (L01EA02) dasatinib (adm: O) | SPRYCEL 50MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Bristol-MyersSquibbCompany |
| USA | (L01EA02) dasatinib (adm: O) | SPRYCEL 70MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Bristol-MyersSquibbCompany |
| USA | (L01EA02) dasatinib (adm: O) | SPRYCEL 70MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Bristol-MyersSquibbCompany |
Pages
